Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

A 22-year-old woman with a rare genetic condition was successfully treated to develop normal female characteristics and regular menstruation.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

The guidelines ensure accurate genetic testing and reporting for 21-hydroxylase deficiency.

Removing the ovaries can help treat hair loss caused by high androgen levels in postmenopausal women.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

Lower testosterone levels in men may be linked to a higher risk of severe coronary artery disease.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Early diagnosis of PSIS can lead to normal height with growth hormone and testosterone treatment.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

The document concludes that scalp disorders can be treated with hair washing, specific shampoos, medications, and sometimes surgery or hair transplants, but hereditary baldness is untreatable.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Trilostane effectively treated hair loss in Alaskan Malamutes with no adverse effects.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.